Please use this identifier to cite or link to this item:
http://cmuir.cmu.ac.th/jspui/handle/6653943832/56007
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Baralee Punyawudho | en_US |
dc.contributor.author | Noppaket Singkham | en_US |
dc.contributor.author | Narukjaporn Thammajaruk | en_US |
dc.contributor.author | Theera Dalodom | en_US |
dc.contributor.author | Stephen J. Kerr | en_US |
dc.contributor.author | David M. Burger | en_US |
dc.contributor.author | Kiat Ruxrungtham | en_US |
dc.date.accessioned | 2018-09-05T03:07:40Z | - |
dc.date.available | 2018-09-05T03:07:40Z | - |
dc.date.issued | 2016-12-01 | en_US |
dc.identifier.issn | 17512441 | en_US |
dc.identifier.issn | 17512433 | en_US |
dc.identifier.other | 2-s2.0-84996607034 | en_US |
dc.identifier.other | 10.1080/17512433.2016.1235972 | en_US |
dc.identifier.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84996607034&origin=inward | en_US |
dc.identifier.uri | http://cmuir.cmu.ac.th/jspui/handle/6653943832/56007 | - |
dc.description.abstract | © 2016 Informa UK Limited, trading as Taylor & Francis Group. Introduction: Therapeutic drug monitoring (TDM) may be beneficial when applied to antiretroviral (ARV). Even though TDM can be a valuable strategy in HIV management, its role remains controversial. Areas covered: This review provides a comprehensive update on important issues relating to TDM of ARV drugs in HIV-infected patients. Articles from PubMed with keywords relevant to each topic section were reviewed. Search strategies limited to articles published in English. Expert commentary: There is evidence supporting the use of TDM in HIV treatment. However, some limitations need to be considered. The evidence supporting the use of routine TDM for all patients is limited, as it is not clear that this strategy offers any advantages over TDM for selected indications. Selected groups of patients including patients with physiological changes, patients with drug-drug interactions or toxicity, and the elderly could potentially benefit from TDM, as optimized dosing is challenging in these populations. | en_US |
dc.subject | Medicine | en_US |
dc.subject | Pharmacology, Toxicology and Pharmaceutics | en_US |
dc.title | Therapeutic drug monitoring of antiretroviral drugs in HIV-infected patients | en_US |
dc.type | Journal | en_US |
article.title.sourcetitle | Expert Review of Clinical Pharmacology | en_US |
article.volume | 9 | en_US |
article.stream.affiliations | Chiang Mai University | en_US |
article.stream.affiliations | The HIV Netherlands Australia Thailand Research Collaboration | en_US |
article.stream.affiliations | University of New South Wales (UNSW) Australia | en_US |
article.stream.affiliations | Academic Medical Centre, University of Amsterdam | en_US |
article.stream.affiliations | Radboud University Nijmegen Medical Centre | en_US |
article.stream.affiliations | Chulalongkorn University | en_US |
Appears in Collections: | CMUL: Journal Articles |
Files in This Item:
There are no files associated with this item.
Items in CMUIR are protected by copyright, with all rights reserved, unless otherwise indicated.